BayFirst Restates Financials, Books $40M in Charges, Flags Control Weaknesses
BAFN sits 32% above its 52-week low of $4.259.
Summary
BayFirst Financial disclosed a $40.1 million asset resolution charge and restated prior financials due to misstated loan costs, deepening losses. The company is evaluating material weaknesses in internal controls and pursuing executive compensation clawbacks.
Key Events · Legal and Risk Events · BAFN
-
Asset Resolution Plan Hits $40.1M
The company booked a $37.0 million charge on its government guaranteed loan portfolio, a $1.5 million impairment on an equity investment, and a $1.6 million write-down on USDA loan premiums.
-
Financial Restatement Announced
2024 net income restated from $12.6M to $11.4M; 2025 net loss deepened from $22.9M to $24.2M; Q1 2026 net loss widened from $5.7M to $5.9M due to misstated deferred origination costs and accrued interest.
-
Internal Control Weaknesses Flagged
Management is evaluating whether the misstatements indicate material weaknesses in internal control over financial reporting, with findings to be disclosed in amended filings.
-
Executive Compensation Clawback Initiated
The company is undertaking a recovery analysis of incentive-based compensation paid to executive officers during the affected periods.
Analysis · BAFN · Finance
BayFirst disclosed a $37 million asset resolution charge, $3.1 million in additional impairments, and a restatement of prior financials due to misstated loan costs and interest. The restatement reduces 2024 net income by $1.2 million and deepens 2025 and Q1 2026 losses. Management is evaluating potential material weaknesses in internal controls and clawing back executive compensation. This follows a deeply dilutive $80 million capital raise and regulatory capital shortfall, compounding distress. The restatement and control issues raise serious governance and financial reporting concerns.
At the time of this filing, BAFN was trading at $5.63 on NASDAQ in the Finance sector, with a market capitalization of approximately $23.5M. The 52-week trading range was $4.26 to $15.28. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.